CN105223362A - Campylobacter jejuni enzyme-linked immunologic detecting kit - Google Patents

Campylobacter jejuni enzyme-linked immunologic detecting kit Download PDF

Info

Publication number
CN105223362A
CN105223362A CN201510572362.2A CN201510572362A CN105223362A CN 105223362 A CN105223362 A CN 105223362A CN 201510572362 A CN201510572362 A CN 201510572362A CN 105223362 A CN105223362 A CN 105223362A
Authority
CN
China
Prior art keywords
campylobacter jejuni
kit
antibody
monoclonal antibody
4c9e1g7h3
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201510572362.2A
Other languages
Chinese (zh)
Other versions
CN105223362B (en
Inventor
方水琴
万绍业
郭慧琴
杨标
胡永辉
刘箐
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SHANGHAI PRAJNA BIOLOGY TECHNIQUE Ltd
Original Assignee
SHANGHAI PRAJNA BIOLOGY TECHNIQUE Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SHANGHAI PRAJNA BIOLOGY TECHNIQUE Ltd filed Critical SHANGHAI PRAJNA BIOLOGY TECHNIQUE Ltd
Priority to CN201510572362.2A priority Critical patent/CN105223362B/en
Publication of CN105223362A publication Critical patent/CN105223362A/en
Application granted granted Critical
Publication of CN105223362B publication Critical patent/CN105223362B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911Bacteria
    • G01N33/56922Campylobacter
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/205Assays involving biological materials from specific organisms or of a specific nature from bacteria from Campylobacter (G)

Abstract

The invention discloses a kind of enzyme linked immunological kit for detecting campylobacter jejuni.Described kit contains the monoclonal antibody that two strains can be incorporated into campylobacter jejuni specifically, one strain is specially as the monoclonal antibody 3G2D8H3G9 catching antibody, CGMCC? No.8766, does is another strain the monoclonal antibody 4C9E1G7H3 as detecting antibody, CGMCC? No.8457.A large amount of test confirms, kit of the present invention can special, detect campylobacter jejuni efficiently, but and other 91 kinds of encountered pathogenic bacterium no cross reactions, be the pathogenetic bacteria testing product that a kind of performance is fabulous.

Description

Campylobacter jejuni enzyme-linked immunologic detecting kit
Technical field
The invention belongs to biotechnology and field of immunology, be specifically related to a kind of enzyme linked immunological kit detecting campylobacter jejuni.
Background technology
Campylobacter jejuni (campylobacterjejunienteritis) is that Butzler in 1973 etc. separate in Feces of Patients With Diarrhea, has been familiar with one of its Main Pathogenic Bacteria for mankind's diarrhoea at present.The incidence of disease of campylobacter jejuni enteritis exceedes bacillary dysentery in developed country, and in developing country, the incidence of disease is almost equal to bacillary dysentery.This bacterium is as important food-borne pathogens, along with food enter enteron aisle after containing breeding rapidly under micro amount of oxygen environment, main infringement jejunum, ileum and colon, invasion and attack intestinal mucosa, cause hyperemia and heamorrhagic lesions, observe some bacterial strain in recent years and can produce similar cholera enterotoxin, cause liquid secretion in enteric cavity to increase.
The detection of current campylobacter jejuni depends on the biochemical identification of GB defined, and its shortcoming is that complex operation, sense cycle are longer, cannot adapt to a large amount of sample examinations.Immunology detection is quick, accurate, the most stable quick detection means occurred in recent years; but there is no the quick testing product that can apply to detect practice both at home and abroad at present; this patent is detect target with campylobacter jejuni, and technology required for protection relates to the quick testing product of campylobacter jejuni.
Summary of the invention
The object of this invention is to provide a kind of kit detecting campylobacter jejuni.
And then the invention provides a kind of enzyme linked immunological kit for detecting campylobacter jejuni, described kit contains:
(a) solid phase carrier, described solid phase carrier is coated with the anti-campylobacter jejuni monoclonal antibody 3G2D8H3G9 as catching antibody, described anti-campylobacter jejuni monoclonal antibody 3G2D8H3G9 is produced by mouse hybridoma cell system 3G2D8H3G9, CGMCCNo.8766;
(b) container a, anti-campylobacter jejuni monoclonal antibody 4C9E1G7H3 as detecting antibody is housed in described container a, described anti-campylobacter jejuni monoclonal antibody 4C9E1G7H3 is produced by mouse hybridoma cell system 4C9E1G7H3, CGMCCNo.8457.
In a preference, described solid phase carrier is enzyme reaction plate.
In another preference, described detection antibody is with detectable label.
In another preference, described detectable label is horseradish peroxidase.
In another preference, described kit is also containing positive control and negative control.
In another preference, described positive control is the campylobacter jejuni bacterium liquid of deactivation, and described negative control is the brucella broth of sterilizing.
The details of various aspects of the present invention is able to detailed description by chapters and sections subsequently.By hereafter and the description of claim, feature of the present invention, object and advantage will be more obvious.
Accompanying drawing explanation
The SDS-PAGE electrophoretogram of Fig. 1 monoclonal antibody of the present invention
Lane1:4C9E1G7H3,Lane3:3G2D8H3G9。
Embodiment
The research of the present inventor shows, using campylobacter jejuni as immunogene, immunity Balb/c mouse, separation and purification obtains the anti-campylobacter jejuni monoclonal antibody of two strains, i.e. 3G2D8H3G9, preserving number CGMCCNo.8766 and 4C9E1G7H3, preserving number CGMCCNo.8457, the antibody titer of above-mentioned two strain monoclonal antibodies can reach 1:100000, its can specificity, be combined with campylobacter jejuni efficiently.Using said monoclonal antibody 3G2D8H3G9 bag by enzyme reaction plate as seizure antibody, with the said monoclonal antibody 4C9E1G7H3 of horseradish peroxidase-labeled as detection antibody, make enzyme-linked immunologic detecting kit.Result shows, and above-mentioned campylobacter jejuni detection kit detection sensitivity reaches 10 5cfu/ml, have repeatability, advantage that accuracy is good, between hole, error is less than 5%, and in plate, CV is less than 3%.Its with singly increase Liszt, hog cholera sramana, mouse typhus sramana, enteritis sramana, Fu Shi will is congratulated, Song Nei Shi will is congratulated, Boydii will is congratulated, enterohemorrhagic Escherichia coli O 157: H7, Enterobacter sakazakii, 91 kinds of equal no cross reactions of bacterium altogether such as small intestine Yersinia ruckeri.
On this basis, the present inventor and then according to DASELISA immunization, through repeatedly testing, finally obtain a kind of can fast, the enzyme linked immunological kit of efficient detection food source property campylobacter jejuni.
Antibody
The present invention includes the anti-campylobacter jejuni monoclonal antibody of two strains.The anti-campylobacter jejuni monoclonal antibody of two strain of the present invention can utilize mouse hybridoma cell system 3G2D8H3G9 (CGMCCNo.8766) and mouse hybridoma cell system 4C9E1G7H3 (CGMCCNo.8457) to secrete generation respectively.
The present invention includes the monoclonal antibody of the corresponding amino acid sequence with anti-campylobacter jejuni monoclonal antibody 3G2D8H3G9 and 4C9E1G7H3, and there is other protein of these chains or protein conjugate and fusion expressed product.Particularly, the present invention includes and have containing hypervariable region (complementary determining region, any protein of light chain CDR) and heavy chain or protein conjugate and fusion expressed product (i.e. immune conjugate and fusion expressed product), as long as this hypervariable region is identical with the hypervariable region of heavy chain with light chain of the present invention or at least 90% homology, preferably at least 95% homology.As is known to the person skilled in the art, immune conjugate and fusion expressed product comprise: that medicine, toxin, cell factor (cytokine), radioactive nuclide, enzyme and other diagnosis or treatment molecule are combined with anti-campylobacter jejuni monoclonal antibody or its fragment and the conjugate that formed.The present invention also comprises the cell surface marker thing or antigen that are combined with anti-campylobacter jejuni monoclonal antibody or its fragment.
For anti-campylobacter jejuni monoclonal antibody heavy of the present invention and sequence of light chain, can measure by conventional method.Hypervariable region or complementary determining region (complementaritydeterminingregion, the CDR) of anti-campylobacter jejuni monoclonal antibody V chain are interesting especially, because relate to conjugated antigen at least partly in them.Therefore, the present invention includes those and there is the band light chain immunoglobulin of CDR and the molecule of weight chain variable chain, as long as its CDR and anti-campylobacter jejuni monoclonal antibody CDR has the homology of more than 90% (preferably more than 95%).The present invention not only comprises complete monoclonal antibody, also comprises and has immunocompetent antibody fragment, as Fab or (Fab ') 2fragment; Heavy chain of antibody; Light chain of antibody.
Present invention also offers the DNA molecular of above-mentioned immunoglobulin (Ig) or its fragment.The sequence of these DNA moleculars can use routine techniques, utilizes mouse hybridoma cell system 3G2D8H3G9 (CGMCCNo.8766) and 4C9E1G7H3 (CGMCCNo.8457) to obtain.In addition, also the coded sequence of light chain and heavy chain can be merged, form single-chain antibody.
Once obtain relevant sequence, just relevant sequence can be obtained in large quantity with recombination method.This is normally cloned into carrier, then proceeds to cell, is then separated from the host cell after propagation by conventional method and obtains relevant sequence.
In addition, also relevant sequence can be synthesized, when especially fragment length is shorter by the method for Prof. Du Yucang.Usually, by first synthesizing multiple small fragment, and then carry out connect can obtain the very long fragment of sequence.
At present, the DNA sequence dna of code book invention albumen (or its fragment, or derivatives thereof) can be obtained completely by chemosynthesis.Then this DNA sequence dna can be introduced in the various existing DNA molecular (or as carrier) that in this area, oneself knows and cell.In addition, also by chemosynthesis, sudden change is introduced in protein sequence of the present invention.
The invention still further relates to the carrier comprising above-mentioned suitable DNA sequence dna and suitable promoter or control sequence.These carriers may be used for transforming suitable host cell, with can marking protein.
Host cell can be prokaryotic, as bacterial cell; Or the eukaryotic such as low, as yeast cells; Or higher eucaryotic cells, as mammalian cell.
Can carry out with routine techniques well known to those skilled in the art with recombinant DNA transformed host cell.When host be prokaryotes as Enterohemorrhagic E.coli time, the competent cell that can absorb DNA can be gathered in the crops at exponential growth after date, uses CaC1 2method process, step used is well-known in this area.Another kind method uses MgC1 2.If needed, transform and also can be undertaken by the method for electroporation.When host is eucaryote, following DNA transfection method can be used: calcium phosphate precipitation, conventional mechanical methods as microinjection, electroporation, liposome packaging etc.
The transformant obtained can be cultivated by conventional method, expresses the polypeptide of coded by said gene of the present invention.According to host cell used, nutrient culture media used in cultivation can be selected from various conventional medium.Cultivate under the condition being suitable for host cell growth.When after host cell growth to suitable cell density, the promoter selected with the induction of suitable method (as temperature transition or chemical induction), cultivates a period of time again by cell.
Recombinant polypeptide in the above methods can be expressed or be secreted into extracellular in cell or on cell membrane.If needed, can utilize its physics, the albumen of being recombinated by various separation method abstraction and purification with other characteristic of chemistry.These methods are well-known to those skilled in the art.The example of these methods includes, but are not limited to: conventional renaturation process, combination by protein precipitant process (salting-out method), centrifugal, the broken bacterium of infiltration, ultrasonic process, ultracentrifugation, sieve chromatography (gel filtration), adsorption chromatography, ion-exchange chromatography, high performance liquid chroma-tography (HPLC) and other various liquid chromatography (LC) technology and these methods.
Anti-campylobacter jejuni monoclonal antibody 4C9E1G7H3 and 3G2D8H3G9 of the present invention, its height of tiring (can 1:100000 be reached), campylobacter jejuni can be detected specifically, efficiently, with singly increase Liszt, hog cholera sramana, mouse typhus sramana, enteritis sramana, Fu Shi will is congratulated, Song Nei Shi will is congratulated, Boydii will is congratulated, enterohemorrhagic Escherichia coli O 157: H7, Enterobacter sakazakii, small intestine Yersinia ruckeri etc. amount to 91 kinds of bacteriums (strain) all no cross reactions, this is maximum innovative point of the present invention.Said monoclonal antibody 4C9E1G7H3 can use horseradish peroxidase, alkaline phosphatase, nanogold particle to mark, and uses in specific manner as detecting antibody.Said monoclonal antibody 3G2D8H3G9, in various detection is used, can use as catching antibody in specific manner.
Detection kit
The present inventor is through to study widely and test, be surprised to find that, after the anti-campylobacter jejuni monoclonal antibody adopting mouse hybridoma cell system 3G2D8H3G9 (CGMCCNo.8766) to produce is as seizure antibody capture campylobacter jejuni, the anti-campylobacter jejuni monoclonal antibody produced by mouse hybridoma cell system 4C9E1G7H3 (CGMCCNo.8457) marked with detectable label is again as detection antibody, extremely effectively can be incorporated into campylobacter jejuni, thus detect campylobacter jejuni in high sensitivity by double-antibody method.
As used herein, described " sample " refers to the materials such as food, human and animal excreta, vomitus, includes but not limited to: the enrichment liquid of serum, blood plasma, ight soil, food etc.Preferably, described sample is food.
As used herein, described " seizure antibody ", " coated antibody ", " first antibody " and " primary antibodie " is used interchangeably, all refer to the described monoclonal antibody that can be incorporated into campylobacter jejuni specifically, it is produced by mouse hybridoma cell system 3G2D8H3G9 (CGMCCNo.8766).
Described seizure antibody can be coated on solid phase carrier.The present invention has no particular limits adopted solid phase carrier, if its can with seizure antibody phase coupling (connection).Such as, described solid phase carrier is enzyme reaction plate.
As used herein, described " detection antibody ", " second antibody ", " enzyme labelled antibody " was used interchangeably with " two resist ", all refer to can specific binding in another strain monoclonal antibody of campylobacter jejuni, it is produced by mouse hybridoma cell system 4C9E1G7H3 (CGMCCNo.8457).
As used herein, described " specificity " refers to that antibody can only be incorporated into campylobacter jejuni; More particularly, refer to that those can be combined with campylobacter jejuni but nonrecognition and be incorporated into the antibody of other non related antigen molecule.
The present inventor and then according to double antibodies sandwich ratio juris, has prepared a kind of enzyme linked immunological kit that can be used for detecting sample jejuni.The way of double-antibody method routine is that seizure antibody is fixed on carrier, then antibody and antigen-reactive is caught, after washing, (described detection antibody carries detectable with detection antibody response again, or can be combined with the material carrying detectable), finally carry out chemiluminescence or enzyme connection chromogenic reaction detection signal.Further, for the kit based on a strain monoclonal antibody, the how anti-development of a strain, the kit measurement effect developed by two strain monoclonal antibodies is more excellent, and degree of accuracy, specificity and stability have more advantage.
Specifically, enzyme linked immunological kit of the present invention contains:
(a) enzyme reaction plate, described enzyme reaction plate is coated with the anti-campylobacter jejuni monoclonal antibody 3G2D8H3G9 as catching antibody, described anti-campylobacter jejuni monoclonal antibody 3G2D8H3G9 is produced by mouse hybridoma cell system 3G2D8H3G9 (CGMCCNo.8766);
(b) container a, anti-campylobacter jejuni monoclonal antibody 4C9E1G7H3 as detecting antibody is housed in described container a, and described anti-campylobacter jejuni monoclonal antibody 4C9E1G7H3 is produced by mouse hybridoma cell system 4C9E1G7H3 (CGMCCNo.8457).
As optimal way of the present invention, described detection antibody is with detectable label.
As used herein, described " detectable label " refers to that whether and the mark of the amount existed existence for determining detected sample jejuni.Determining seizure antibody that kit of the present invention adopts and/or after detecting antibody, this area can adopted conventional for being combined with detection antibody the various labels carrying out detecting.The present invention has no particular limits adopted label, as long as can be combined with described detection antibody, and can indicate exactly after appropriate processing the existence of detected sample jejuni whether and the label of amount be all available.Described label directly can be arranged at and detect on antibody; Or described label also can be arranged on the antiantibody of the anti-detection antibody of specificity, those skilled in the art according to the kind of adopted antibody and characteristic, can select suitable label.Such as, described label can be selected from: horseradish peroxidase (HRP), alkaline phosphatase vinegar enzyme (AP), glucose oxidase, beta-D-galactosidase, urase, hydrogen peroxidase or glucoamylase.
When adopting some enzyme marker as implied above, also need the substrate adopting some to be combined with corresponding enzyme, thus report label by modes such as colour developings there is situation or amount.As used herein, described " substrate corresponding with label " refers to and can be labeled thing institute catalyzed coloration, for showing the identification signal detecting antibody and campylobacter jejuni and occur to combine.Described substrate is such as: for adjacent benzene two limb (OPD), tetramethyl biphenyl limb (TMB), the ABTS of horseradish peroxidase; For p-nitrophenyl phosphoric acid vinegar (p-nitrophenylphosphate, p-NPP) etc. of alkaline phosphatase.Those skilled in the art according to the kind of adopted label and characteristic, can select suitable substrate.
As optimal way of the present invention, described detection antibody is directly connected with label.More preferably, described label is HRP.With detect antibody with biotin labeling, react after compare with streptavidin HRP reacting phase again, directly detection antibody on mark HRP, reaction terminate after directly add substrate colour developing more simple and convenient.
In order to obtain quantitative result, the standard items knowing multiple campylobacter jejunis of concentration containing oneself can also be set in testing process.Method to set up for standard items can adopt conventional method.
In order to eliminate false positive and false negative, also Quality Control (contrast) can be set in testing process.As optimal way of the present invention, described positive control is the campylobacter jejuni bacterium liquid of deactivation, and described negative control is the brucella broth (Brucellabroth) of sterilizing.
In addition, in order to make kit of the present invention more convenient when detecting, preferably some other auxiliary reagent is also comprised in described kit, described auxiliary reagent is conventional some reagent used in ELISA kit, and the characteristic of these reagent and their compound method are all well-known to those skilled in the art.Described reagent is (but being not limited to) such as: developer, cleansing solution, stop buffer, enrichment liquid, dilution.
In addition, in described kit, also operation instructions can be comprised, for illustration of the using method of the reagent wherein loaded.
Cleaning Principle and the beneficial effect of enzyme linked immunological kit of the present invention are as follows:
What kit of the present invention adopted is DASELISA immunization.Anti-campylobacter jejuni monoclonal antibody (seizure antibody) is had when pre-coated on enzyme reaction plate, after adding sample solution or standard items, add with the anti-campylobacter jejuni monoclonal antibody of detectable label another strain as horseradish peroxidase (detection antibody) again, the campylobacter jejuni existed in sample or standard items will combine with seizure antibody enzyme reaction plate wrapping quilt, after detection antibody to be added, " antibody-antigen-enzyme labelled antibody " compound can be formed, yellow substance can be formed after TMB (tetramethyl benzidine) colour developing, thus can judgement sample jejuni existence whether and the amount existed.
Under 450nm, absorbance is measured by microplate reader.Negative control≤0.1, positive control >=0.3, experimental result is effective, otherwise result be judged to be invalid; During detect aperture OD value >=0.2, be judged to be the positive; When detect aperture OD value is between 0.1-0.2, be judged to be the weak positive; Detect aperture OD value≤0.1 is judged to be feminine gender.
Test shows, campylobacter jejuni enzyme linked immunological kit of the present invention, has higher sensitivity and accuracy.Between plate, error is less than 5%, and in plate, CV is less than 3%.With singly increase Liszt, hog cholera sramana, mouse typhus sramana, enteritis sramana, Fu Shi will is congratulated, Song Nei Shi will is congratulated, Boydii will is congratulated, enterohemorrhagic Escherichia coli O 157: H7, Enterobacter sakazakii, small intestine Yersinia ruckeri etc. amount to 91 kinds of bacteriums (strain) all no cross reactions, this is maximum innovative point of the present invention.
In a word, kit of the present invention requires low, easy and simple to handle to the pre-treatment of sample, and detection limit is 10 5cfu/ml, specificity and good stability, and all there is no cross reaction with most of food-borne pathogens.
Below in conjunction with specific embodiment, set forth the present invention further.Should be understood that these embodiments are only not used in for illustration of the present invention to limit the scope of the invention.The experimental technique of unreceipted actual conditions in the following example, usual conveniently condition is as people such as Sambrook, molecular cloning: lab guide (NewYork:ColdSpringHarborLaboratoryPress, 1989) condition described in, or according to the condition that manufacturer advises.Unless otherwise indicated, otherwise number percent and number calculate by weight.
Unless otherwise defined, all specialties used in literary composition and scientific words and one skilled in the art the meaning be familiar with identical.In addition, any method similar or impartial to described content and material all can be applicable in the present invention.The use that better implementation method described in literary composition and material only present a demonstration.
The preparation of the anti-campylobacter jejuni monoclonal antibody 4C9E1G7H3 and 3G2D8H3G9 of embodiment 1.
One, the preparation of immunogene and positive criteria product
Campylobacter jejuni (CICCNo.22937) is seeded on brucella broth, 37 DEG C, 150r/min shaken cultivation 17h, and counting, adds 0.3% formalin room temperature deactivation 1 day.Campylobacter jejuni (CICCNo.22937) concentration to 5 × 10 are adjusted with physiological saline 9cfu/ml is as immunogene; Adjusting concentration with physiological saline is 10 8cfu/ml is as positive control standard items, and brucella broth is negative control standard items.
Two, the preparation of monoclonal antibody
1, animal used as test: select 38 week ages, about body weight 20g, female Balb/c mouse are animal used as test.
2, immunization method: every mouse peritoneal injection 0.2ml immunogene, at interval of 2 weeks with same dosage booster shots once.
3, take a blood sample: from tail vein blood sampling after 3 booster immunizations, adopt indirect non-competing euzymelinked immunosorbent assay (ELISA) to measure antiserum titre.Wait to tire and no longer rise, lumbar injection same amount immunogene, conventionally carried out Fusion of Cells after 3 days.
4, Fusion of Cells: get that immune mouse spleen cell and SP2/0 myeloma cell are conventional under 50%PEG effect merges, is inoculated in 96 well culture plates respectively, is placed in 37 DEG C, 5%CO 2incubator is cultivated.
5, filtering hybridoma: adopt indirect non-competing euzymelinked immunosorbent assay (ELISA), the hybridoma in screening strong positive hole, transfers them to 24 well culture plates.
6, clone cultivates and antibody preparation: carry out colonized culture with limiting dilution assay.When Growth of Cells is to when to be paved with at the bottom of hole 1/10, then detect with same method, strong positive hole is cloned, 3-4 time so repeatedly, until positive rate reaches 100% again.Hybridoma is expanded and cultivates, be injected in through the pretreated Balb/c mouse peritoneal of paraffin oil, every 2 × 10 6individual hybridoma, 7 ~ 10 days mouse web portion protuberances, living body puncture extracts ascites.
Three, monoclonal antibody-purified and qualification
After ascites is first slightly carried with caprylic acid-ammonium, then purify with ProteinGSepharose affinity chromatography; Antibody after purifying measures with indirect elisa method and tires (see table 1) after doubling dilution; Use SDS-PAGE purity assay again, 5% spacer gel, 10% separation gel, 120V voltage, bottom electrophoresis to glue, gel Coomassie Brilliant Blue dyes, Labworks image acquisition and analysis software observations (see Fig. 1) after decolouring.
Table 1. liang strain antibody titer measurement result (OD 450)
The CHARACTERISTICS IDENTIFICATION of embodiment 2. monoclonal antibody 4C9E1G7H3 and 3G2D8H3G9
One, monoclonal antibody subgroup identification
1, antigen coated: with 0.01MPBS bag by goat against murine two anti-igg+A+M, every hole 50 μ l, 4 DEG C of bags are spent the night, and discard liquid in hole next day, wash plate 3 times.
2, close: every hole adds 1%BSA200 μ l, close for 4 DEG C and spend the night.Next day pats dry plank and does not wash plate.
3, monoclonal antibody hybridoma cell supernatant is added, each sample 8 micropores, every hole 50 μ l.37 DEG C, hatch 1h.
4, after washing plate 4 times, the rabbit anti-mouse igg 1, IgG2a, IgG2b, IgG3, IgA, IgM, κ, λ, 37 DEG C adding specific bond respectively hatches 1h.
5, after washing plate 4 times, every hole adds horseradish peroxidase-labeled anti-rabbit two anti-igg (H+L) of having diluted, and 37 DEG C, hatches 30min.
6, after washing plate 4 times, 100 μ l substrate nitrite ions are added, 37 DEG C, lucifuge colour developing 10min.Result is read under 450nm wavelength.
As shown in table 2, H3 belongs to IgG2a subclass, and G9 belongs to IgG1 subclass.
Table 2. liang strain monoclonal antibody subgroup identification result
Two, monoclonal antibody cross reaction test
1, antigen coated: by 96 kind 10 8the pathogenic bacteria of cfu/ml bacterial concentration join in ELISA Plate, and each pathogenic bacteria add 3 each holes, and every hole 100 μ l, wraps and spent the night by 4 DEG C.
2, close: after washing plate 3 times, every hole adds 3%BSA200 μ l, hatches 2h for 37 DEG C.
3, plate is washed 3 times.Every hole adds the monoclonal antibody 100 μ l diluted, and hatches 1h for 37 degrees Celsius.
4, plate is washed 3 times.Adding the goat against murine two of having diluted resists in all micropores, and every hole 100 μ l, hatches 1h for 37 degrees Celsius.
5, plate is washed 4 times.Add substrate nitrite ion, 37 DEG C, lucifuge colour developing 15min.Result is read under 450nm wavelength.
Table 3. liang strain monoclonal antibody cross reaction testing result
Embodiment 3. detects the composition of the enzyme linked immunological kit of campylobacter jejuni, preparation and application thereof
One, enzyme linked immunological kit is made up of following substances
(1) ELISA Plate of pre-coated antibody: wrap by 96 hole ELISA Plate with 0.02M acetate buffer solution (pH2.0) solution dilution, anti-campylobacter jejuni monoclonal antibody 3G2D8H3G9, every hole 100 μ l.4 DEG C of overnight incubation, conveniently ELISA method closes washing.
(2) campylobacter jejuni positive control standard items and negative control standard items.
(3) the monoclonal antibody 4C9E1G7H3 of the anti-campylobacter jejuni of horseradish peroxidase-labeled.
(4) enzyme labelled antibody dilution: 0.01MPBS, pH7.6.
(5) 10 × concentrated washing lotion: the 0.1M phosphate buffer containing 0.5% Tween-20 and 0.2% Sodium azide, pH7.4, dilutes concentrated washing lotion 10 times during use.
(6) nitrite ion A liquid, nitrite ion B liquid.Before using, A liquid is mixed with B liquid equal-volume.
(7) stop buffer: 2M sulfuric acid solution.
Two, the preparation of each component in enzyme linked immunological kit
(1) using campylobacter jejuni monoclonal antibody 3G2D8H3G9 as seizure antibody coated elisa plate
Be buffered liquid with bag and campylobacter jejuni monoclonal antibody 3G2D8H3G9 is diluted to 5 μ g/ml, every hole adds 100 μ l, 4 DEG C are spent the night, incline next day coating buffer, with the wash liquid diluted 3 times, pats dry, then in every hole, add 220 μ l confining liquids, 37 DEG C of incubation 2h, liquid in hole of inclining, preserves with aluminium foil bag sealing after drying.
Bag is buffered liquid: 0.02M acetate buffer solution, regulates pH to 2.0 with 5MHCl.
Confining liquid: the 0.01MPBS containing 0.3% bovine serum albumin(BSA) and 10% sucrose.
(2) preparation of the monoclonal antibody 4C9E1G7H3 of horseradish peroxidase-labeled
Campylobacter jejuni monoclonal antibody 4C9E1G7H3 and horseradish peroxidase (HRP) are carried out coupling, and the method for employing is the Over-voltage protection of improvement, and method is as follows:
A, 5mg horseradish peroxidase (HRP) is dissolved in 0.5ml0.2M acetate buffer solution (pH5.6).
B, add the 0.06MNaIO of existing preparation 4solution 0.5ml, 4 DEG C of oxidation 20min.
C, add 0.4M ethylene glycol solution 0.5ml containing 22%NaCl, room temperature leaves standstill 30min.
The absolute ethyl alcohol precipitation enzyme of d, use 6ml precooling, the centrifugal 10min of 1500rpm.
E, remove supernatant, precipitation is dissolved in the 0.01MPBS (pH7.4) of 2.5ml.
F, add 10mg monoclonal antibody 4C9E1G7H3, and use 0.5M carbonic acid buffer (pH9.6) to regulate pH to 9.0 immediately.4 DEG C of hold over night.
G, add 10mg/ml sodium borohydride 50 μ l, 4 DEG C, leave standstill 2h.
H, use 0.01MPBS (pH7.4) 4 DEG C of dialysed overnight.
I, purification storage.
Three, the application of kit
(1) detection method
1, sample pre-treatments
Get measuring samples 25g (ml) and add the homogeneous mixing under homogenizer of 225ml brucella broth, cultivate 16h for 36 DEG C ± 1 DEG C.Cultured sample is heated 10min in 100 DEG C of water-baths, and it is stand-by that taking-up is cooled to room temperature.
2, detect with kit
30min is placed under the micropore of taking-up requirement and all reagent normal temperature.Getting 200 μ l measuring samples is added in micropore, 37 DEG C, hatches 30min.Remove liquid in hole, add 200 μ l washing lotions in each micropore, rock the several seconds gently, fast upset is by liquid in micropore to the greatest extent, to a folded clean thieving paper clap several under, repeat operation and wash plate altogether 3 times.Add 100 μ l monoclonal antibody linked with peroxidase 4C9E1G7H3 working fluids, 37 DEG C, hatch 60min.Remove liquid in hole and wash plate 4 times.Colour developing A liquid and colour developing B liquid mixed in equal amounts are made into substrate nitrite ion.Each micropore adds the substrate nitrite ion of 100 μ l, room temperature lucifuge colour developing 15-20min.Add stop buffer 100 μ l, under 450nm, measure absorbance by microplate reader.
Result judges: negative control≤0.1, positive control >=0.3, and experimental result is effective, otherwise result be judged to be invalid; During detect aperture OD value >=0.2, be judged to be the positive; When detect aperture OD value is between 0.1-0.2, be judged to be the weak positive; Detect aperture OD value≤0.1 is judged to be feminine gender.
If without microplate reader, can with the naked eye judge: Positive control wells has macroscopic yellow, negative control hole is without color, and experimental result is effective, otherwise is judged to be that experimental result is invalid; Be positive findings when detect aperture has obvious macroscopic yellow; When having faint yellow, be judged to be weak positive findings; Without during naked eyes visible yellow color being negative findings.
(2) detection of enzyme linked immunological kit effect
1, kit repeatability and stability test
Precision test in plate: get 6 micropores in same ELISA Plate, test with the milk crossed by jejunum campylobacter fungi pollution, experiment repetition 4 times.
Precision test between plate: 4 pieces of ELISA Plate of getting same batch, tests with the milk crossed by jejunum campylobacter fungi pollution, experiment repetition 3 times.
The computing method of the coefficient of variation: the coefficient of variation (the CV)=standard deviation of measurement result and the number percent of its mean value.
Reperformance test result in table 4. plate
Reperformance test result between table 5. plate
2, kit cross reaction test
Go to detect other 91 kinds of food-borne pathogens and conventional food Carried bacteria with kit, whether checking kit detects the specificity of campylobacter jejuni, observe and have cross reaction and false positive to occur with other pathogenic bacteria.
Table 6. kit specificity is tested
Note: "+" represents that testing result is positive; "-" represents that testing result is negative.
3, kit storage life experiment
Kit preservation condition is 2-8 DEG C, and after 12 months, the testing result of kit is consistent with the kit results of new lot.Consider in transport and use procedure that having improper preservation condition occurs, placed 8 days under 37 DEG C of conditions of preserving by kit, carry out accelerated aging test, result shows that the indices of kit meets the requirements completely.Therefore kit at least can preserve more than 12 months at 2-8 DEG C.
The preservation of biomaterial
Produce and be preserved in (No. 3, Yard 1, BeiChen xi Road, Chaoyang District, Beijing City, China Committee for Culture Collection of Microorganisms's common micro-organisms center (CGMCC) through the hybridoma cell strain 3G2D8H3G9 of the campylobacter jejuni monoclonal antibody of above-mentioned qualification on January 9th, 2014, Institute of Microorganism, Academia Sinica, postcode: 100101), Classification And Nomenclature is " anti-campylobacter jejuni hybridoma ", and preserving number is CGMCCNo.8766.
Produce and be preserved in (No. 3, Yard 1, BeiChen xi Road, Chaoyang District, Beijing City, China Committee for Culture Collection of Microorganisms's common micro-organisms center (CGMCC) through the hybridoma cell strain 4C9E1G7H3 of the vibrio parahemolyticus monoclonal antibody of above-mentioned qualification on November 15th, 2013, Institute of Microorganism, Academia Sinica, postcode: 100101), Classification And Nomenclature is " anti-campylobacter jejuni hybridoma ", and preserving number is CGMCCNo.8457.
The all documents mentioned in the present invention are quoted as a reference all in this application, are just quoted separately as a reference as each section of document.In addition should be understood that those skilled in the art can make various changes or modifications the present invention, and these equivalent form of values fall within the application's appended claims limited range equally after having read above-mentioned instruction content of the present invention.

Claims (6)

1. for detecting an enzyme linked immunological kit for campylobacter jejuni, it is characterized in that, described kit contains:
(a) solid phase carrier, described solid phase carrier is coated with the anti-campylobacter jejuni monoclonal antibody 3G2D8H3G9 as catching antibody, described anti-campylobacter jejuni monoclonal antibody 3G2D8H3G9 is produced by mouse hybridoma cell system 3G2D8H3G9, CGMCCNo.8766;
(b) container a, anti-campylobacter jejuni monoclonal antibody 4C9E1G7H3 as detecting antibody is housed in described container a, described anti-campylobacter jejuni monoclonal antibody 4C9E1G7H3 is produced by mouse hybridoma cell system 4C9E1G7H3, CGMCCNo.8457.
2. kit as claimed in claim 1, it is characterized in that, described solid phase carrier is enzyme reaction plate.
3. kit as claimed in claim 1, it is characterized in that, described detection antibody is with detectable label.
4. kit as claimed in claim 3, it is characterized in that, described detectable label is horseradish peroxidase.
5. kit as claimed in claim 1, is characterized in that, described kit is also containing positive control and negative control.
6. kit as claimed in claim 5, it is characterized in that, described positive control is the campylobacter jejuni bacterium liquid of deactivation, and described negative control is the brucella broth of sterilizing.
CN201510572362.2A 2015-09-10 2015-09-10 Campylobacter jejuni enzyme-linked immunologic detecting kit Active CN105223362B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510572362.2A CN105223362B (en) 2015-09-10 2015-09-10 Campylobacter jejuni enzyme-linked immunologic detecting kit

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510572362.2A CN105223362B (en) 2015-09-10 2015-09-10 Campylobacter jejuni enzyme-linked immunologic detecting kit

Publications (2)

Publication Number Publication Date
CN105223362A true CN105223362A (en) 2016-01-06
CN105223362B CN105223362B (en) 2016-08-31

Family

ID=54992430

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510572362.2A Active CN105223362B (en) 2015-09-10 2015-09-10 Campylobacter jejuni enzyme-linked immunologic detecting kit

Country Status (1)

Country Link
CN (1) CN105223362B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106124772A (en) * 2016-06-15 2016-11-16 金华职业技术学院 A kind of ELISA detection kit based on OMP18 detection campylobacter jejuni and application thereof
CN109884291A (en) * 2017-12-25 2019-06-14 苏州和锐生物科技有限公司 Campylobacter spp polypeptide, antibody capture device and kit

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040185454A1 (en) * 2003-03-21 2004-09-23 Jones Alison M. Identification and quantification of microbial species in a sample
JP2009077658A (en) * 2007-09-26 2009-04-16 Osaka Prefecture Method for quickly detecting campylobacter in feces
WO2011156619A2 (en) * 2010-06-09 2011-12-15 The Board Of Trustees Of The University Of Arkansas Vaccine and methods to reduce campylobacter infection
CN102286437A (en) * 2011-07-01 2011-12-21 中国疾病预防控制中心传染病预防控制所 Specific antigen for detecting campylobacter jejuni antibodies and application thereof
CN102426233A (en) * 2011-11-15 2012-04-25 吉林出入境检验检疫局检验检疫技术中心 Campylobacter jejuni detection method with liquid chip
CN102532283A (en) * 2011-12-20 2012-07-04 江苏出入境检验检疫局动植物与食品检测中心 Specific antibody of campylobacter jejuni specific multi-epitope artificial polypeptide and coated immunomagnetic beads and application thereof

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040185454A1 (en) * 2003-03-21 2004-09-23 Jones Alison M. Identification and quantification of microbial species in a sample
JP2009077658A (en) * 2007-09-26 2009-04-16 Osaka Prefecture Method for quickly detecting campylobacter in feces
WO2011156619A2 (en) * 2010-06-09 2011-12-15 The Board Of Trustees Of The University Of Arkansas Vaccine and methods to reduce campylobacter infection
CN102286437A (en) * 2011-07-01 2011-12-21 中国疾病预防控制中心传染病预防控制所 Specific antigen for detecting campylobacter jejuni antibodies and application thereof
CN102426233A (en) * 2011-11-15 2012-04-25 吉林出入境检验检疫局检验检疫技术中心 Campylobacter jejuni detection method with liquid chip
CN102532283A (en) * 2011-12-20 2012-07-04 江苏出入境检验检疫局动植物与食品检测中心 Specific antibody of campylobacter jejuni specific multi-epitope artificial polypeptide and coated immunomagnetic beads and application thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
沈广 等: "单克隆抗体ELISA快速检测经济动物空肠弯曲菌的研究", 《特产研究》 *
韩文瑜 等: "BA-ELISA检测空肠弯曲菌的研究", 《中国兽医科技》 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106124772A (en) * 2016-06-15 2016-11-16 金华职业技术学院 A kind of ELISA detection kit based on OMP18 detection campylobacter jejuni and application thereof
CN106124772B (en) * 2016-06-15 2018-05-04 金华职业技术学院 A kind of ELISA detection kit and its application based on OMP18 detection campylobacter jejunis
CN109884291A (en) * 2017-12-25 2019-06-14 苏州和锐生物科技有限公司 Campylobacter spp polypeptide, antibody capture device and kit

Also Published As

Publication number Publication date
CN105223362B (en) 2016-08-31

Similar Documents

Publication Publication Date Title
Sunwoo et al. Detection of Escherichia coli O157: H7 using chicken immunoglobulin Y
CN104360065B (en) Vibrio parahemolyticus enzyme-linked immunologic detecting kit
CN103792361B (en) Enzyme-linked immunosorbent assay kit of enterohemorrhagic E.col O157:H7
CN104316690B (en) Vibrio parahemolyticus immune colloid gold Rapid detection test strip
CN103823062B (en) Salmonella choleraesuls enzyme-linked immunologic detecting kit
CN103940995B (en) Listeria monocytogenes enzyme-linked immunologic detecting kit
CN104360066B (en) Detect method and the monoclonal antibody thereof of vibrio parahemolyticus
CN105223362A (en) Campylobacter jejuni enzyme-linked immunologic detecting kit
CN103941011B (en) Detect method and the monoclonal antibody thereof of listeria monocytogenes
CN103777017B (en) Detect method and the monoclonal antibody thereof of enterohemorrhagic Escherichia coli O 157: H7
CN103848916B (en) Preparation method, coded sequence and the application thereof of a kind of anti-CP4 EPSPS monoclonal antibody
CN103823063B (en) Detect method and the monoclonal antibody thereof of Salmonella choleraesuls
CN105223363B (en) The method of detection campylobacter jejuni and monoclonal antibody thereof
CN103913572B (en) Method for detecting staphylococcus aureus and monoclonal antibodies of staphylococcus aureus
CN103869074B (en) Enzyme-linked immunoassay kit for staphylococcus aureus
CN105132282B (en) Campylobacter jejuni immuno-PCR detection kit
CN103820549B (en) Salmonella choleraesuis immune PCR detection kit
CN103823060B (en) Enterohemorrhagic Escherichia coli O 157: H7 immuno-PCR detection kit
CN103937898B (en) Listeria monocytogenes immuno-PCR detection kit
CN105137075B (en) Campylobacter jejuni immune colloid gold Rapid detection test strip
CN106596952A (en) Salmonella cholerae enzyme-linked immunosorbent assay kit
CN103866033B (en) Staphylococcus aureus immune PCR (polymerase chain reaction) detection kit
CN114181909B (en) Hybridoma cell strain, monoclonal antibody thereof and kit
CN103941006B (en) Salmonella choleraesuls immune colloid gold Rapid detection test strip
CN104357565B (en) Vibrio parahemolyticus immuno-PCR detection kit

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant